Added to YB: 2026-04-09
Pitch date: 2026-04-07
IRIX [bullish]
IRIDEX Corporation
-25.77%
current return
Author Info
No bio for this author
Company Info
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology.
Market Cap
$19.7M
Pitch Price
$1.11
Price Target
N/A
Dividend
N/A
EV/EBITDA
-18.45
P/E
-5.89
EV/Sales
0.48
Sector
Health Care Equipment and Supplies
Category
turnaround
A Primer on Iridex
IRIX: Ophthalmic med-tech w/ retina (71% rev) & glaucoma (29% rev) units both growing. Q4/25 adj EBITDA & FCF turned positive after 22% OpEx cut; more cost-cutting via contract mfg by FY27. EU MDR cert expected 2026 to unlock PASCAL upgrade cycle. FY26 guide $51-53M (+1-5%) ex-Middle East. 0.29x EV/S on $15M EV. Consistent insider buying. Upside from aging pop, diabetes rise (700M by 2045), 80-100M glaucoma addressable mkt.
Read full article (4 min)